Formic Acid

Formic Acid

SCHEMBL31744989

Nc1nc(Cc2ccco2)nc2ccsc12.O=CO

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 9/20 0.42
▸ ADORA1 P30542 9/20 0.42
▸ TSHR P16473 4/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ CASP7 P55210 1/20 0.39
▸ APAF1 O14727 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ CACNA1B Q00975 1/20 0.36
▸ APBA1 Q02410 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ UBE2N P61088 2/20 0.36
▸ POLB P06746 3/20 0.35
▸ GAA P10253 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ PDE4A P27815 1/20 0.34
▸ PDE4B Q07343 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31744975 0.93 ADORA1 (0.47) ADORA2AADORA1TSHRHSD17B10CASP1
SCHEMBL31745005 0.72 ADORA1 (0.54) ADORA2AADORA1TSHRKMT2AALDH1A1
SCHEMBL31685021 0.70 DCPS (0.46) ADORA2ATSHRHSD17B10CASP1CASP7
Formic Acid SCHEMBL30763130 0.69 ADORA2A (0.50) ADORA2AADORA1NPC1RAB9APOLB
Formic Acid SCHEMBL31745012 0.69 ADORA2A (0.38) ADORA2AADORA1TSHRHSD17B10NPC1
Trifluoroacetic Acid SCHEMBL31745076 0.69 ADORA1 (0.46) ADORA2AADORA1KMT2AALDH1A1PDE4A
Formic Acid SCHEMBL6130009 0.68 POLB (0.55) ADORA2AADORA1TSHRHSD17B10NPC1
Formic Acid SCHEMBL31744976 0.67 ADORA2A (0.36) ADORA2AADORA1RAB9AKMT2AALDH1A1
Trifluoroacetic Acid SCHEMBL31220481 0.66 KDM4E (0.39) TSHRHSD17B10CASP1CASP7NPC1
Formic Acid SCHEMBL30317221 0.65 ALDH1A1 (0.34) TSHRHSD17B10CASP1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382305-A1 COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 PTC THERAPEUTICS INC (US) 2025-12-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382305-A1 COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 ATXN2, SMN1; SMN2, ATXN10 ADORA2A 1286/4885ADORA1 2438/4885TSHR 3917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback